KMKerri Melehan

Kerri Melehan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kerri Melehan has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Camilla Miranda Hoyos

    Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research Macquarie University Sydney New South Wales Australia

    5 shared publications
  • Nathaniel Stuart Marshall

    School of Health Sciences and Nursing, Faculty of Medicine, Health and Human Sciences Macquarie University New South Wales Australia

    5 shared publications
  • Brendon J. Yee

    Woolcock Institute of Medical Research, The University of Sydney, NSW, Australia; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, NSW, Australia

    4 shared publications
  • Ronald R. Grunstein

    NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS), Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia

    4 shared publications
  • Sharon Linda Naismith

    University of Sydney

    4 shared publications
  • Simon John Geoffrey Lewis

    Parkinson’s Disease Research Clinic, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia

    4 shared publications

Latest Publications

  • Open Access

    Temporally Continuous Automated Sleep-Wake Classification Using Deep Learning

    by Pranavan Somaskandhan, Henri Korkalainen, Timo Leppänen, Juha Toyras, Kerri Melehan, Warren Ruehland, Scott A. Sands, Dwayne L. Mann, Danielle L. Wilson, Philip I. Terrill

    Introduction: Segmenting sleep into fixed 30-second epochs remains central to current sleep scoring practice, yet it imposes rigid boundaries that may not accurately reflect the true temporal sleep dynamics. We aimed to develop a deep learning-based, high-temporal-resolution sleep-wake classifier leveraging temporally continuous manual reference scoring without fixed epoch boundaries and transfer learning techniques to facilitate progress toward a more physiologically consistent sleep assessment. Methods: Three independent datasets were utilized, of which two included sleep-wake scoring manually conducted in a temporally continuous manner. A U-Net based model was initially trained on a large dataset scored using 30-second epochs, with post hoc scoring modifications ( n =2034). It was then fine-tuned via transfer learning using a subset of one of the datasets with temporally continuous scoring ( n =39) and validated on both its holdout portion ( n =40) and the other independent temporally continuous scoring dataset ( n =20). Wakefulness and arousals were consolidated, acknowledging their shared physiological characteristics. Prediction confidence estimates were also generated. Results: The model achieved overall concordance of 88.96% ( κ =0.78) and 88.23% ( κ =0.76) in the holdout and second independent evaluation dataset, respectively, with temporally continuous scoring. Correlation between 1-second automatic predictions and temporally continuous manual scoring was r =0.93 ( p r =0.67 ( p <0.001) for sleep-to-wake transition index. Conclusions: These findings support the utility of our model in addressing key limitations of 30-second epoch-based scoring and progressing toward more physiologically consistent sleep-wake assessment by providing a practical basis for subsequent analyses. Misclassifications generally showed lower confidences, indicating additional value for targeted review. Statement of Significance: Conventional sleep scoring remains constrained by fixed 30-second epochs, which may fail to capture the true temporal dynamics of the underlying changes between sleep and wakefulness. In this study, we used polysomnography data manually scored on a temporally continuous basis as the gold standard to develop and validate a deep learning model capable of classifying sleep and wakefulness-like states (consolidating wakefulness and arousal) at high temporal resolution without fixed 30-second epochs. The model demonstrated strong agreement with the gold standard, and as such, lays a practical foundation for deriving improved physiologically meaningful biomarkers of sleep fragmentation and continuity, with potential diagnostic and prognostic value and broad applicability toward a more precise and physiologically consistent sleep assessment.


  • Open Access

    Patient preference of level I, II and III sleep diagnostic tests to diagnose obstructive sleep apnoea among pregnant women in early to mid-gestation

    by Frances Clements, Hima Vedam, Yewon Chung, Nathaniel S. Marshall, Kerri Melehan, Annemarie Hennessy, Angela Makris

    Purpose: There is a paucity of data on preferences for obstructive sleep apnoea (OSA) diagnostic tests during pregnancy. Simple test completion rates fail to capture patient preference or experience of completing sleep diagnostic tests. We assessed preference, ease of use, convenience, and the repeatability of level I, II and III sleep diagnostic tests, using questionnaires, in pregnant women in early to mid-gestation. Methods: Pregnant women with signs or symptoms of OSA, or at high risk of cardiometabolic disorders of pregnancy completed level I, II and III sleep studies by 24 weeks gestation. Participants then completed a questionnaire to rank test preference. Additional questionnaires assessed ease of use, convenience, and acceptability to repeat test, using 5-point Likert scale questions, yes/no response and optional linked text fields. Results: Of fifty-two consented participants, 43 completed any questionnaire (mean age 32.7 ± 5.4 years, BMI 32.7 ± 5.4, median gestation at Level I polysomnography (PSG) of 14.2 weeks (interquartile range (IQR) 13.5–17.6)). Of the 29 respondents who completed test ranking questionnaire, level III was the preferred test ((n = 21 / 29, 75%)), followed by level 1 (n = 6 / 29, 20.7%) and level II (n = 2 / 29, 7.1%) (p for diff < 0.001). Level III was reported the easiest test (very easy to complete) (n = 16, 51.6%), followed by level I(n = 10, 33.3%), and level II (n = 9, 9.1%) (p for diff < 0.001)). Level III was reported most convenient test (very convenient to complete) (n = 16, 51.6%), followed by level I (n = 4, 13.3%) and level II (n = 4, 13.3%) (p for diff < 0.001)). Level III was reported most acceptable to repeat (very acceptable to repeat) (n = 13, 41.9%), followed by level I (n = 3, 10.0%) and level II (n = 3, 10.0%) (p for diff < 0.001)). Conclusion: Pregnant women being assessed for OSA by 24 weeks gestation preferred to undertake level III sleep studies and found level III easier to use, more convenient and most acceptable to repeat than Level I and II studies. Given autonomy is an important principle, patient preference of sleep diagnostic tests should be taken into consideration in sleep clinical services and research involving pregnant women.


  • Open Access

    Validation of self-applied unattended polysomnography using Somte V2 PSG (Somte) for diagnosis of obstructive sleep apnoea (OSA) in pregnant women in early to mid-gestation

    by Frances Clements, Angela Makris, Yewon Chung, Jonathon Poh, Nathaniel S. Marshall, Kerri Melehan, Renuka Shanmugalingam, Annemarie Hennessy, Hima Vedam

    Purpose: Polysomnography (PSG) may be completed in the home environment (unattended), and when self-applied, allow the collection of data with minimal healthcare worker intervention. Self-applied, unattended PSG in the home environment using Somte PSG V2 (Somte) has not been validated in pregnant women in early to mid-gestation. We undertook a study to evaluate the accuracy of Somte compared to attended PSG. The agreement between apnoea hypopnea index (AHI) and respiratory disturbance index (RDI) scores in Somte and PSG in early to mid-gestation were assessed. Methods: Pregnant women (≤ 24 weeks gestation) were scheduled for PSG and Somte within a 7-day window, in any order. Somte were self-applied and completed in the home. Somte were scored blinded to PSG result. AHI was the primary outcome of interest, though an AHI ≥ 5 or RDI ≥ 5 on PSG was considered diagnostic of Obstructive Sleep Apnoea (OSA). AHI, RDI, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) was calculated and receiver operating characteristic (ROC) curves were produced. Bland–Altman plots were used to determine agreement. Technical issues occurring during tests were explored. Results: Twenty-four participants successfully completed both tests between March 2021 and January 2023. PSG were completed at around 14.1 weeks’ gestation (IQR 13.4, 15.7). The time interval between Somte and PSG was a median of 4 days (IQR 2, 7 (range 1–12)). Five (20.8%) women had OSA on PSG at AHI ≥ 5 and 10 (41.6%) women had OSA on PSG at RDI ≥ 5. Somte and PSG did not differ in the measurement of AHI ((1.8, 1.6, p = 0.09) or RDI (3.3, 3.5), p = 0.73). At AHI ≥ 5, diagnostic test accuracy (area under the ROC curve) of Somte was 0.94, sensitivity 80.0%, specificity 94.7%, PPV and NPV were 80.0% and 94.7% respectively. At RDI ≥ 5, diagnostic test accuracy (area under the ROC curve) was 0.95, sensitivity 60.0%, specificity 93.0% and PPV and NPV were 85.7% and 76.4% respectively. The confidence limits of Bland–Altman plots were 6.37 to − 8.89 at cut off AHI ≥ 5 and 8.89 to − 10.43 at cut off RDI ≥ 5. Somte failed to start in four tests. Technical issues were reported in both Somte (n = 13, 54.2%) and PSG (n = 6, 25.0%). Conclusion: Self-applied, unattended Somte may provide an acceptable substitute to attended PSG in the identification of OSA in pregnant women in early to mid-gestation in this small sample but may fail to detect cases of OSA, particularly when using RDI as the diagnostic marker.


  • Validation of the Apnealink Air for diagnosis of obstructive sleep apnoea (OSA) in pregnant women in early-mid gestation

    by Frances Clements, Angela Makris, Yewon Chung, Nathaniel S. Marshall, Kerri Melehan, Renuka Shanmugalingam, Annemarie Hennessy, Hima Vedam

    Purpose The detection of obstructive sleep apnoea (OSA) in pregnant women in early-mid gestation is logistically difficult. Accurate alternates to polysomnography (PSG) in early pregnancy are not well identified. We compared the agreement between Apnealink Air (AL) and existing screening questionnaires to PSG in pregnant women ≤ 24-week gestation. Methods Pregnant women (≤ 24-week gestation) underwent AL at home plus attended PSG in any order, completed within 7 days where practicable. AL was manually scored (AL(M)) and automatically scored (AL(A)). An apnoea-hypopnea index (AHI) ≥ 5 was considered diagnostic of OSA and an AHI ≥ 15 considered at least moderate OSA. Diagnostic analysis was undertaken (sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV)) by generating receiver operating characteristic (ROC) curves and an area under the curve (AUC) (95% CI). Bland–Altman plots were used to plot agreement. Screening questionnaires (Epworth sleepiness score (ESS), STOP-BANG, calculated pregnancy-specific screening tool) were compared to PSG. Results A total of 49 participants successfully completed both tests at around 14-weeks gestation (IQR 12.9, 17.1). The time interval between AL and PSG was a median of 2 days (IQR 1, 5 (range 1–11)). A total of 14 (29%) participants had OSA. The median AHI of AL(A) (3.1(IQR 0.85,4.6)) and AL(M) (IQR2.4(0.65,4.8)) did not differ from PSG (1.7(IQR1.0,6.1)). AL(A) and AL(M) compared to PSG demonstrated diagnostic test accuracy (area under curve (ROC)) of 0.94(95% CI 0.87–1.0) and 0.92(95% CI 0.85–1.0) respectively. Apnealink Air outperformed screening questionnaires tested. Conclusion The findings suggest that Apnealink may provide a substitute to attended PSG identification of OSA in pregnant women in early-mid gestation using both manual and auto-scoring methods.


  • Open Access

    Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo‐controlled study

    by K. L. Melehan, C. M. Hoyos, B. J. Yee, K. K. Wong, P. R. Buchanan, R. R. Grunstein, P. Y. Liu

    Summary: Testosterone (T) deficiency, sexual dysfunction, obesity and obstructive sleep apnea (OSA) are common and often coexist. T prescriptions have increased worldwide during the last decade, including to those with undiagnosed or untreated OSA. The effect of T administration on sexual function, neurocognitive performance and quality of life in these men is poorly defined. The aim of this study was to examine the impact of T administration on sexual function, quality of life and neurocognitive performance in obese men with OSA. We also secondarily examined whether baseline T might modify the effects of T treatment by dichotomizing on baseline T levels pre‐specified at 8, 11 and 13 nmol/L. This was a randomized placebo‐controlled study in which 67 obese men with OSA (mean age 49 ± 1.3 years) were randomized to receive intramuscular injections of either 1000 mg T undecanoate or placebo at baseline, week 6 and week 12. All participants were concurrently enrolled in a weight loss program. General and sleep‐related quality of life, neurocognitive performance and subjective sexual function were assessed before and 6, 12 and 18 weeks after therapy. T compared to placebo increased sexual desire (p = 0.004) in all men, irrespective of baseline T levels. There were no differences in erectile function, frequency of sexual attempts, orgasmic ability, general or sleep‐related quality of life or neurocognitive function (all p = NS). In those with baseline T levels below 8 nmol/L, T increased vitality (p = 0.004), and reduced reports of feeling down (p = 0.002) and nervousness (p = 0.03). Our findings show that 18 weeks of T therapy increased sexual desire in obese men with OSA independently of baseline T levels whereas improvements in quality of life were evident only in those with T levels below 8 nmol/L. These small improvements would need to be balanced against potentially more serious adverse effects of T therapy on breathing.


  • Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literature

    by Camilla M. Hoyos, Kerri L. Melehan, Peter Y. Liu, Ronald R. Grunstein, Craig L. Phillips


  • To ED or not to ED – Is erectile dysfunction in obstructive sleep apnea related to endothelial dysfunction?

    by Camilla M. Hoyos, Kerri L. Melehan, Craig L. Phillips, Ronald R. Grunstein, Peter Y. Liu


  • Open Access

    Metabolic and hormonal effects of ‘catch‐up’ sleep in men with chronic, repetitive, lifestyle‐driven sleep restriction

    by Roo Killick, Camilla M. Hoyos, Kerri L. Melehan, George C. Dungan, Jonathon Poh, Peter Y. Liu

    Summary: Objective: Acutely restricting sleep worsens insulin sensitivity in healthy individuals whose usual sleep is normal in duration and pattern. The effect of recovery or weekend ‘catch‐up’ sleep on insulin sensitivity and metabolically active hormones in individuals with chronic sleep restriction who regularly ‘catch‐up’ on sleep at weekends is as yet unstudied.Design: 19 men (mean ± SEM age 28·6 ± 2·0 years, BMI 26·0 ± 0·8 kg/m2) with at least 6 months’ history (5·1 ± 0·9 years) of lifestyle‐driven, restricted sleep during the working week (373 ± 6·6 min/night) with regular weekend ‘catch‐up’ sleep (weekend sleep extension 37·4 ± 2·3%) completed an in‐laboratory, randomized, crossover study comprising two of three conditions, stratified by age. Conditions were 3 weekend nights of 10 hours, 6 hours or 10 hours time‐in‐bed with slow wave sleep (SWS) suppression using targeted acoustic stimuli.Measurements: Insulin sensitivity was measured in the morning following the 3rd intervention night by minimal modelling of 19 samples collected during a 2‐h oral glucose tolerance test. Glucose, insulin, c‐peptide, leptin, peptide YY (PYY), ghrelin, cortisol, testosterone and luteinizing hormone (LH) were measured from daily fasting blood samples; HOMA‐IR, HOMA‐β and QUICKI were calculated.Results: Insulin sensitivity was higher following three nights of sleep extension compared to sustained sleep restriction. Fasting insulin, c‐peptide, HOMA‐IR, HOMA‐β, leptin and PYY decreased with ‘catch‐up’ sleep, QUICKI and testosterone increased, while morning cortisol and LH did not change. Targeted acoustic stimuli reduced SWS by 23%, but did not alter insulin sensitivity.Conclusions: Three nights of ‘catch‐up’ sleep improved insulin sensitivity in men with chronic, repetitive sleep restriction. Methods to improve metabolic health by optimizing sleep are plausible.


  • Methodology for the Assessment of Sleep

    by Christopher B. Miller, Simon D. Kyle, Kerri L. Melehan, Delwyn J. Bartlett


  • Investigating the night-to-night variability of REM without atonia in Parkinson's disease

    by Samuel J. Bolitho, Sharon L. Naismith, Zoe Terpening, Ron R. Grunstein, Kerri Melehan, Brendon J. Yee, Alessandra Coeytaux, Simon J.G. Lewis